0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug/Vaccine Safety
 41-60 of 213 Articles
From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2014;311(12):1246. doi:10.1001/jama.2014.339.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(11):1097-1098. doi:10.1001/jama.2014.1697.

JAMA Clinical Evidence Synopsis | 
Karsten M. H. Bruins Slot, MD, PhD; Eivind Berge, MD, PhD
JAMA. 2014;311(11):1150-1151. doi:10.1001/jama.2014.1403.

Global Health | 
M. J. Friedrich
JAMA. 2014;311(11):1101. doi:10.1001/jama.2014.2580.

Capitol Health Call | 
Mike Mitka, MSJ
JAMA. 2014;311(10):1005. doi:10.1001/jama.2014.1175.

News From the Centers for Disease Control and Prevention | 
JAMA. 2014;311(10):1006. doi:10.1001/jama.2014.1616.

News From the Centers for Disease Control and Prevention | 
JAMA. 2014;311(10):1007. doi:10.1001/jama.2014.1622.

Research Letter |  FREE
Deborah A. Zarin, MD; Tony Tse, PhD; Jerry Menikoff, MD, JD
JAMA. 2014;311(9):960-961. doi:10.1001/jama.2013.284306.

news@JAMA | 
JAMA. 2014;311(9):893. doi:10.1001/jama.2014.1221.

JAMA Patient Page |  FREE
Jill Jin, MD, MPH
JAMA. 2014;311(9):978. doi:10.1001/jama.2013.285612.
Includes: Supplemental Content

Editorial | 
David Goldblatt, MBChB, PhD; Elizabeth Miller, FRCPath
JAMA. 2014;311(8):804-805. doi:10.1001/jama.2014.471.

The Medical Letter on Drugs and Therapeutics | 
JAMA. 2014;311(7):731-732. doi:10.1001/jama.2014.202.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(6):560-561. doi:10.1001/jama.2014.481.

Medical News & Perspectives | 
Mike Mitka, MSJ
JAMA. 2014;311(6):563. doi:10.1001/jama.2014.716.

Medical News & Perspectives | 
Mike Mitka, MSJ
JAMA. 2014;311(5):454-455. doi:10.1001/jama.2013.285786.

Editorial | 
Steven N. Goodman, MD, MHS, PhD; Rita F. Redberg, MD, MSc
JAMA. 2014;311(4):361-363. doi:10.1001/jama.2013.283946.

JAMA Revisited | 
JAMA. 2014;311(4):423. doi:10.1001/jama.2013.279299.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;311(4):347-348. doi:10.1001/jama.2013.285704.

news@JAMA | 
JAMA. 2014;311(4):348. doi:10.1001/jama.2013.286120.

Clinical Trials Update | 
Anita Slomski
JAMA. 2014;311(4):349. doi:10.1001/jama.2014.61.

Sign in

Purchase Options

• Subscribe to the journal

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Internal Medicine
Original Investigation  | 
Rates of Opioid Dispensing and Overdose After Introduction of Abuse-Deterrent Extended-Release Oxycodone and Withdrawal of Propoxyphene
Marc R. Larochelle, MD, MPH; Fang Zhang, PhD; Dennis Ross-Degnan, ScD; et al.
JAMA Ophthalmology
Original Investigation  | 
Additive Intraocular Pressure–Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost:  A Report of 2 Randomized Clinical Trials
Hidenobu Tanihara, MD; Toshihiro Inoue, MD; Tetsuya Yamamoto, MD; et al.
JAMA Oncology
Original Investigation  | 
Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone:  Analyses of Data From 2 Women’s Health Initiative Randomized Clinical Trials
Rowan T. Chlebowski, MD, PhD; Thomas E. Rohan, PhD; JoAnn E. Manson, MD, DrPH; et al.
JAMA Oncology
Special Communication  | 
Patient-Reported Outcomes in Cancer Drug Development and US Regulatory Review:  Perspectives From Industry, the Food and Drug Administration, and the Patient
Ethan Basch, MD, MSc; Cindy Geoghegan, BA; Stephen Joel Coons, PhD; et al.